Published in

Elsevier, Lung Cancer, (133), p. 48-55, 2019

DOI: 10.1016/j.lungcan.2019.04.027

Links

Tools

Export citation

Search in Google Scholar

Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219

Journal article published in 2019 by Barbara Melosky ORCID, Penelope Bradbury, Dongsheng Tu, Marie Florescu, Anthony Reiman, Garth Nicholas, Naveen Basappa, Jeffrey Rothenstein, John R. Goffin, Scott A. Laurie ORCID, Paul Wheatley-Price, Natasha Leighl, Glenwood Goss, M. Neil Reaume, Charles Butts and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO